Enjoy complimentary customisation on priority with our Enterprise License!
The global gastroscopes market size is estimated to grow by USD 340.9 million at a Compound annual growth rate (CAGR) of 4.36% between 2023 and 2028. The rising incidence of gastrointestinal disorders, including diverticulosis, various intestinal diseases, gastrointestinal cancers, and urinary and fecal incontinences, presents considerable challenges to healthcare systems worldwide. Consequently, endoscopic procedures, particularly gastroscopy, are crucial for the early detection, efficient management, and prevention of these conditions. Gastroscopy allows medical professionals to detect abnormalities, conduct biopsies, and undertake therapeutic procedures effectively. Therefore, the capability of gastroscopy to facilitate the early diagnosis of digestive disorders is anticipated to drive the expansion of the market in the coming years.
To learn more about this report, Request Free Sample
The market share growth by the hospital segment will be significant during the forecast period. Gastroscopes are commonly used in hospitals to perform various diagnostic and therapeutic procedures related to gastrointestinal (GI) disorders. A gastrointestinal endoscopy procedure is needed to diagnose many gastrointestinal conditions, including gastritis, peptic ulcers, gastroesophageal reflux disease (GERD), Barrett's esophagus, and gastrointestinal cancer.
Get a glance at the market contribution of various segments View a PDF Sample
The hospital segment was valued at USD 623.40 million in 2018. Hospitals also depend on gastroscopes to perform therapeutic procedures. Gastroenterologists use them to treat conditions like bleeding ulcers, remove polyps, dilate strictures, and manage other gastrointestinal abnormalities. These minimally invasive procedures offer patients effective treatment options with shorter recovery times. Considering the wide range of gastrointestinal conditions encountered in the hospital, the demand for gastroscopy is high, which is expected to boost the growth of the global gastroscope market in the hospital segment during the forecast period.
The flexible gastroscope is an essential and commonly used medical instrument in the field of gastroenterology. The main benefit of the flexible gastroscope is its ability to access different parts of the upper gastrointestinal tract, including the esophagus, stomach, and duodenum, without much discomfort to the patient. The insert can be smoothly maneuvered, providing a clear view of the internal structure and assisting in the diagnosis of various gastrointestinal conditions. The flexible gastroscope is equipped with a high-quality camera at the tip, which captures real-time high-definition images of the digestive tract. These images are displayed on a screen, allowing the endoscopist to view and examine the mucosa, identify abnormalities, and detect conditions such as gastritis, peptic ulcers, and GERD. Thus, such advantages of the flexible gastroscope will drive the growth of the market during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. Both the US and Canada have well-developed and robust healthcare infrastructures, making North America a key region for the adoption and use of advanced medical technologies such as gastroscopy.
In addition, the region is home to many well-equipped hospitals, clinics, and gastroenterology centers that perform a large number of endoscopic procedures. These centers allow gastroenterologists to perform a wide range of diagnostic and therapeutic procedures using the endoscope. Furthermore, the presence of key market players such as Conmed Corp, Stryker Corp, Johnson, and Johnson Services Inc., and Laborie Medical Technologies Corp will drive the growth of the market in this region during the forecast period.
In the realm of diagnostic procedures, especially for conditions like Coeliac disease and stomach cancer, therapeutic interventional approaches are crucial. Flexible gastroscopes enable precise examination while maintaining sterile solutions to prevent cross-contamination and mitigate restoration costs. Healthcare professionals rely on robust methodologies for strategic planning and investment decisions aimed at achieving investment targets in emerging economies. Advanced tools such as esophagoscopes aid in diagnosing ailments like obesity and enable robotics-assisted procedures. These innovations extend to pediatric gastroscopes, ensuring pet health and addressing digestive abnormalities like dysphagia. Managing healthcare expenditure requires efficient use of resources, including techniques like esophagoscopy to detect cancer cells early. This integrated approach underscores the importance of technological advancements in enhancing diagnostic accuracy and therapeutic outcomes across diverse medical conditions and patient demographics.
Increasing incidence of gastrointestinal disorders is the key factor driving the growth of the market. Gerontology diseases disproportionately affect the aging population, with prominent gastrointestinal disorders such as diverticulosis, bowel diseases, gastrointestinal malignancies, and urinary and fecal-related problems. Changes in lifestyles, such as the increase in unhealthy diets and physical inactivity, will result in high blood pressure, blood glucose, lipids, and obesity. In the past few years, there has been a rise in morbidity and mortality from chronic diseases, such as esophageal cancer, colorectal cancer, rectal cancer, and gastrointestinal-related critical disorders. According to the American Cancer Society, it is estimated that about 93,000 new cases of colorectal cancer and 40,000 new cases of rectal cancer are diagnosed every year in the US. Conditions such as esophageal perforations, bile duct injury, and gallstones require gastrointestinal stents as a remedial procedure, which is considered a supplementary procedure.
Moreover, according to the American Gastroenterological Association, irritable bowel syndrome (IBS) impacts nearly 35 million Americans every year, causing recurring constipation, diarrhea, and abdominal pain. The rising prevalence of gastrointestinal disorders poses challenges to healthcare systems, necessitating the need for early detection, effective management, and preventive measures. Gastroscopy and other endoscopic procedures play a vital role in the diagnosis and treatment of these conditions, allowing healthcare providers to identify abnormalities, conduct biopsies, and perform therapeutic interventions. Thus, the increasing incidence of gastrointestinal disorders is expected to drive the growth of the global gastroscopes market during the forecast period.
The incorporation of artificial intelligence (AI) into gastroscopes and endoscopy systems stands as a pivotal driver propelling market expansion. AI's utilization in gastroscopy primarily revolves around image analysis, where AI algorithms scrutinize real-time images captured by the gastroscope, effectively identifying suspicious lesions imperceptible to the naked eye. Moreover, AI-powered image analysis aids in lesion characterization, distinguishing between benign and malignant lesions, and predicting malignancy risks. Such insights empower healthcare professionals to render more precise diagnoses, enhance patient care, and mitigate unnecessary invasive procedures.
Additionally, AI contributes to optimizing endoscopic unit performance by assessing exam adequacy, measuring wait times, and offering process feedback, thereby standardizing processes, minimizing variability, and augmenting endoscopic examination quality. This surge in AI integration within gastroscopy and endoscopy systems is poised to propel market growth in the foreseeable future.
Stringent regulations for the approval of gastrointestinal devices affect the growth of the market. Regulators have introduced a strict regulatory framework and labeling requirements for medical devices. Medical devices undergo safety assessments to demonstrate their medical effectiveness before being approved. The FDA prevents dangerous and ineffective devices from entering or remaining on the market. As a result, a large portion of devices on the market have not yet been approved by the Food and Drug Administration (FDA)
However, the failure to comply with these laws and regulations can have a negative impact on market expansion. Some devices undergo rigorous clinical testing prior to approval and require pre-market approval (PMA). Sometimes an extensive agency review process is followed for certain devices. Therefore, the strict regulation for the approval of gastrointestinal devices could become a major challenge and impede the growth of the market during the forecast period.
Buy Now Full Report and Discover More
The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Conmed Corp.: The company offers gastroscopes devices such as Biliary and Endoscopic Ultrasound devices.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
Endoscopy Devices Market: Endoscopy Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast
Veterinary Endoscopy Devices Market: Global Veterinary Endoscopy Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, France - Size and Forecast
ENT Devices Market: ENT Devices Market by Product, End-user, and Geography - Forecast and Analysis
In the field of medical diagnostics and interventions, endoscopes play a pivotal role, ranging from laparoscopic instruments to bronchoscopes and arthroscopes. These devices are essential for examining various anatomical regions with precision, utilizing advanced endoscopes such as video gastroscopes and transnasal gastroscopes for enhanced visibility and patient comfort. Specialized components and robotics integration further enhance capabilities, catering to diverse needs from routine examinations to complex procedures. For the geriatric population and health-conscious consumers, technologies like rigid gastroscopes and dual-channel endoscopes ensure effective diagnosis and treatment of conditions such as inflammatory bowel diseases. Regulatory and macroeconomic variables influence the adoption of these technologies, impacting prevalence rates and healthcare strategies. Veterinary medicine benefits from veterinary gastroscopes, adapting similar innovations for animal health. This dynamic landscape underscores the continuous evolution of medical instruments and techniques, driven by advancements in control sections and the pursuit of optimal patient outcomes.
Market Scope |
|
Report Coverage |
Details |
Page number |
152 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.36% |
Market growth 2023-2027 |
USD 340.9 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.11 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Germany, UK, Japan, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advin Health Care, Arthrex Inc., B.Braun SE, Boston Scientific Corp., Carl Zeiss AG, Conmed Corp., Endomed Systems GmbH, FUJIFILM Corp., HOYA Corp., HUGER Medical Instrument Co. Ltd., Johnson and Johnson, KARL STORZ SE and Co. KG, LABORIE MEDICAL TECHNOLOGIES CORP., Medtronic Plc, Mitra Group, Olympus Corp., Richard Wolf GmbH, Smith and Nephew plc, Stryker Corp., and dantschke Medizintechnik GmbH and Co. KG |
Market dynamics |
Parent market analysis, Market forecasting growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.